• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓来源的干细胞启动胰腺再生。

Bone marrow-derived stem cells initiate pancreatic regeneration.

作者信息

Hess David, Li Li, Martin Matthew, Sakano Seiji, Hill David, Strutt Brenda, Thyssen Sandra, Gray Douglas A, Bhatia Mickie

机构信息

Robarts Research Institute, Stem Cell Biology and Regenerative Medicine, 100 Perth Drive, London, Ontario N6A 5K8, Canada.

出版信息

Nat Biotechnol. 2003 Jul;21(7):763-70. doi: 10.1038/nbt841. Epub 2003 Jun 22.

DOI:10.1038/nbt841
PMID:12819790
Abstract

We show that transplantation of adult bone marrow-derived cells expressing c-kit reduces hyperglycemia in mice with streptozotocin-induced pancreatic damage. Although quantitative analysis of the pancreas revealed a low frequency of donor insulin-positive cells, these cells were not present at the onset of blood glucose reduction. Instead, the majority of transplanted cells were localized to ductal and islet structures, and their presence was accompanied by a proliferation of recipient pancreatic cells that resulted in insulin production. The capacity of transplanted bone marrow-derived stem cells to initiate endogenous pancreatic tissue regeneration represents a previously unrecognized means by which these cells can contribute to the restoration of organ function.

摘要

我们发现,移植表达c-kit的成年骨髓源细胞可降低链脲佐菌素诱导的胰腺损伤小鼠的高血糖水平。尽管对胰腺的定量分析显示供体胰岛素阳性细胞的频率较低,但在血糖降低开始时这些细胞并不存在。相反,大多数移植细胞定位于导管和胰岛结构,它们的存在伴随着受体胰腺细胞的增殖,从而导致胰岛素产生。移植的骨髓源干细胞启动内源性胰腺组织再生的能力代表了一种以前未被认识的这些细胞有助于恢复器官功能的方式。

相似文献

1
Bone marrow-derived stem cells initiate pancreatic regeneration.骨髓来源的干细胞启动胰腺再生。
Nat Biotechnol. 2003 Jul;21(7):763-70. doi: 10.1038/nbt841. Epub 2003 Jun 22.
2
Bone marrow stem cells find a path to the pancreas.
Nat Biotechnol. 2003 Jul;21(7):755-6. doi: 10.1038/nbt0703-755.
3
Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice.骨髓来源细胞移植促进糖尿病小鼠胰岛修复。
Biochem Biophys Res Commun. 2008 Jun 20;371(1):132-7. doi: 10.1016/j.bbrc.2008.04.033. Epub 2008 Apr 15.
4
Formation of pancreatic duct epithelium from bone marrow during neonatal development.新生儿发育期间骨髓来源的胰腺导管上皮形成。
Stem Cells. 2006 Feb;24(2):307-14. doi: 10.1634/stemcells.2005-0052.
5
Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization.移植的人骨髓祖细胞亚型刺激内源性胰岛再生和再血管化。
Stem Cells Dev. 2012 Jan;21(1):97-109. doi: 10.1089/scd.2010.0583. Epub 2011 Oct 21.
6
Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established.造血干细胞移植可预防非肥胖糖尿病(NOD)小鼠患糖尿病,但一旦疾病确立,对显著的胰岛细胞再生并无贡献。
Exp Hematol. 2005 Jun;33(6):699-705. doi: 10.1016/j.exphem.2005.03.008.
7
Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.同基因骨髓移植逆转小鼠新发1型糖尿病
Biochem Biophys Res Commun. 2008 Sep 19;374(2):282-7. doi: 10.1016/j.bbrc.2008.07.016. Epub 2008 Jul 14.
8
Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice.小鼠部分胰腺切除术后胰岛移植对β细胞再生的促进作用。
Transplantation. 2009 Aug 15;88(3):354-9. doi: 10.1097/TP.0b013e3181b07a02.
9
Bone marrow transplantation stimulates pancreatic β-cell replication after tissue damage.骨髓移植可刺激组织损伤后的胰腺β细胞复制。
Islets. 2009 Jul-Aug;1(1):10-8. doi: 10.4161/isl.1.1.8529.
10
Reversal of experimental diabetes by multiple bone marrow transplantation.多次骨髓移植逆转实验性糖尿病
Biochem Biophys Res Commun. 2005 Mar 4;328(1):318-25. doi: 10.1016/j.bbrc.2004.12.176.

引用本文的文献

1
REST/NRSF Preserves muscle stem cell identity by repressing alternate cell fate.REST/NRSF通过抑制其他细胞命运来维持肌肉干细胞特性。
Nat Commun. 2025 Aug 12;16(1):7487. doi: 10.1038/s41467-025-62758-y.
2
In Vivo Differentiation of Endogenous Bone Marrow-Derived Cells into Insulin-Producing Cells Using Four Soluble Factors.利用四种可溶性因子将内源性骨髓来源细胞在体内分化为胰岛素产生细胞
Diabetes Metab J. 2025 Jan;49(1):150-159. doi: 10.4093/dmj.2024.0174. Epub 2024 Oct 24.
3
Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative.
骨髓细胞源自幼稚或糖尿病小鼠在自身免疫 1 型糖尿病中的作用:免疫调节、抗炎、降血糖和抗氧化。
Endocrine. 2024 Dec;86(3):959-979. doi: 10.1007/s12020-024-03929-7. Epub 2024 Jul 17.
4
Novel lipid mediator 7,14-docosahexaenoic acid: biogenesis and harnessing mesenchymal stem cells to ameliorate diabetic mellitus and retinal pericyte loss.新型脂质介质7,14-二十二碳六烯酸:生物合成及利用间充质干细胞改善糖尿病和视网膜周细胞丢失
Front Cell Dev Biol. 2024 Mar 12;12:1380059. doi: 10.3389/fcell.2024.1380059. eCollection 2024.
5
Mouse islet-derived stellate cells are similar to, but distinct from, mesenchymal stromal cells and influence the beta cell function.胰岛衍生的星状细胞类似于间充质基质细胞,但又有区别,并且能够影响β细胞的功能。
Diabet Med. 2024 Jun;41(6):e15279. doi: 10.1111/dme.15279. Epub 2024 Jan 7.
6
A Supportive Role of Mesenchymal Stem Cells on Insulin-Producing Langerhans Islets with a Specific Emphasis on The Secretome.间充质干细胞对胰岛素分泌性朗格汉斯胰岛的支持作用,特别强调分泌组
Biomedicines. 2023 Sep 18;11(9):2558. doi: 10.3390/biomedicines11092558.
7
Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions.新兴的糖尿病治疗选择:最新趋势、挑战与未来方向。
Int J Obes (Lond). 2023 Dec;47(12):1179-1199. doi: 10.1038/s41366-023-01369-3. Epub 2023 Sep 11.
8
Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats.骨髓间充质干细胞和橙皮素对链脲佐菌素诱导的Wistar大鼠1型糖尿病的治疗效果
Pharmaceuticals (Basel). 2023 Jun 8;16(6):859. doi: 10.3390/ph16060859.
9
Bone-marrow derived cells do not contribute to new beta-cells in the inflamed pancreas.骨髓来源的细胞不会对炎症胰腺中的新β细胞做出贡献。
Front Immunol. 2023 Jan 17;14:1084056. doi: 10.3389/fimmu.2023.1084056. eCollection 2023.
10
Current Advances in the Management of Diabetes Mellitus.糖尿病管理的当前进展
Biomedicines. 2022 Sep 29;10(10):2436. doi: 10.3390/biomedicines10102436.